Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02988700Phase 3Completed
Phase 3, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: FLACC Score at 24 hours. Started Nov 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02988700.